Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Pathology Application Released for iPad and iPhone

By LabMedica International staff writers
Posted on 06 Jul 2011
A digital pathology viewing application with built-in educational content from institutes and pathologists was released for iPad and iPhone. More...


Users can try Digital Pathology for free and view, zoom and navigate digital slides through the high performance viewer. Existing Digital Image Hub users can connect the application to their own server to explore and view images from their own image collection.
SlidePath Gateway provides access to high quality whole slide images captured on the Leica Microsystems (Wetzlar, Germany) SCN400 slide scanner, with expert review findings and content provided by contributing bodies including the American Society for Clinical Pathology (ASCP) CheckPath Anatomical Pathology External Quality Assessment (EQA) Program (2006), Cerviva Cervical Cytology EQA Pilot (2009), National health Service (NHS) Breast Screening Pathology EQA Program (2010), UK National Urologic Pathology EQA Program (2009), and the United Kingdom National External Quality Assessment Service (UKNEQAS) HER2 Breast Interpretive EQA Pilot (2011).

Browsing folders of images from each of the EQA programs is possible. Individual cases can be selected and the user can view, zoom, and navigate around the slides. Each case includes expert pathologist assessments, which can be viewed with the slides, giving increased insight into the samples. They can also see a sample set of Leica Biosystems’ Novocastra antibody range.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories a large product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems said, “The release of the SlidePath Gateway App displays Leica Microsystems’ commitment to develop and expand its Digital Pathology portfolio. With this App we are giving everyone the opportunity to try Digital Pathology, access high resolution whole slide images and expert opinions, through a highly intuitive user interface. With the rapid adoption and acceptance of iPads and other tablet devices in hospitals and clinical settings, we see SlidePath Gateway paving the way for future adoption of Digital Pathology in routine use.”

Related Links:

Leica Microsystems


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.